Drug Type Monoclonal antibody |
Synonyms ICT 41, ICT41 |
Target |
Mechanism BTN3A1 inhibitors(butyrophilin subfamily 3 member A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Imcheck Therapeutics SASStartup |
Active Organization Imcheck Therapeutics SASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Virus Diseases | Preclinical | FR | Imcheck Therapeutics SASStartup | 27 Oct 2023 |